Dr. Lovly is a physician-scientist with a special interest in thoracic malignancies.
She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She completed her graduate students in the laboratory of Helena Piwnica-Worms, PhD.
She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her medical oncology fellowship, she completed research fellowship in the laboratory of William Pao, MD, PhD. During her final year of fellowship, she was the Jim and Carol O'Hare Chief Fellow.
D. Lovly started on faculty at Vanderbilt in July 2013 as an Assistant Professor of Medicine and Cancer Biology in July 2013. Dr. Lovly's clinical practice focuses primarily on the care of patients with lung cancer. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.
She has received independent grant funding from the Damon Runyon Foundation, the V Foundation, LUNGevity, Uniting Against Lung Cancer, AACR, and the Conquer Cancer Foundation of the American Society of Clinical Oncology. She is the author of several peer-reviewed scientific manuscripts, and she is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR).
Dr. Lovly is also the co-Editor-in Chief for the website www.mycancergenome.org, a Vanderbilt initiated, freely available website which aims to provide health care practitioners, patient, and advocates with up-to-date information regarding genetically informed cancer medicine.
The following timeline graph is generated from all co-authored publications.Featured publications are shown below:
2220 Pierce Avenue South
Nashville, TN 37232
MeSH terms are retrieved from PubMed records. Learn more.
Key: MeSH Term KeywordActive Transport, Cell Nucleus Adenocarcinoma, Bronchiolo-Alveolar Amino Acid Sequence Ataxia Telangiectasia Mutated Proteins Carbazoles Disease Progression Dual Specificity Phosphatase 6 Eligibility Determination ErbB Receptors GTP-Binding Protein alpha Subunits HeLa Cells Inhibitory Concentration 50 Male Models, Molecular Molecular Sequence Data Neoplasm Metastasis Neoplasm Staging Oncogene Proteins, Fusion Peptide Fragments Phosphorylation Protein Isoforms Protein Kinase Inhibitors Proteins Pyrazoles Radiation Tolerance Receptor, ErbB-3 Serine Endopeptidases Sirolimus Sulfones Threonine